







































the	oseltamivir	 ring	 framework	 could	 significantly	 increase	 the	 cytotoxicity	 for	 this	 class	 of
compounds.	 Loss	 of	 neuraminidase	 inhibition	 activity	 of	 these	 synthetic	 oseltamivir











Shikimic	 acid	 is	 well	 known	 as	 starting	 material	 for	
production	 of	 oseltamivir	 phosphate	 (Tamiflu),	 an	 active	
neuraminidase	 inhibitor	 [1‐5].	 Although	 of	 some	 reports	 on	
total	 oseltamivir	 synthesis	 from	 other	 sources,	 shikimic	 acid	
remains	the	principal	starting	material	for	making	oseltamivir.	
Shikimic	 acid	 is	 a	 key	 precursor	 for	 an	 enormous	 number	 of	
aromatic	 compounds,	 e.g.	 aromatic	 amino	 acids,	 vitamins	 and	
host	of	secondary	metabolites	[6‐9],	and	is	the	ideal	precursor	
for	tracer	studies	because	it	is	generally	permeable	to	cells	and	
is	 chemically	 stable.	 As	 shikimate	 pathway	 does	 not	 occur	 in	
mammals,	much	 effort	 has	 been	made	 to	 synthesize	potential	
enzyme	 inhibitors	 in	 order	 to	 develop	 antimicrobial	 reagents.	
Many	 of	 these	 compounds,	 by	 virtue	 of	 their	 structural	
similarity	 to	 shikimic	 acid,	 have	 been	 targeted	 as	 likely	
inhibitor	 of	 enzyme	 on	 the	 shikimic	 acid	 pathway	 and	 are	 of	
biological	 interest	 as	 potential	 antifugal	 [10,11],	 antibacterial	
[11],	 antitumor	 [12,13],	 and	 antiparasitic	 agents	 [14].	Besides	
its	 bio‐significance,	 shikimic	 acid,	 which	 is	 a	 highly	 function‐
nalized	 carbocycle,	 is	 also	 an	 industrially	 useful	 chiral	
compound	[15].	In	our	search	of	bioactive	compounds	based	on	
shikimic	 acid,	 we	 reported	 here	 the	 synthesis	 and	 biological	
activity	of	oseltamivir	analogues	containing	either	ether	sulfur	
or	 ether	 oxygen	 at	 C‐3	 position.	 To	 our	 knowledge,	 the	
synthesis	of	oseltamivir	analogues	with	ether	sulfur	at	C‐3	has	
not	 been	 reported	 yet.	 Also,	 there	 are	 a	 few	 reports	 on	 the	
cytotoxicity	 of	 compounds	 based	 on	 shikimic	 acid,	 whereas	
several	 shikimic	 acid’s	 derivatives	 have	 been	 found	 to	 be	
potential	 antitumor	 agents	 such	 as	 pericosines	 [12,16].	
Furthermore,	 the	 plant	 star	 anise	 (Illicium	 verum),	 widely	









Co.	 and	 used	 without	 further	 purification.	 Optical	 rotations	
were	recorded	on	a	Jasco	P‐2000	polarimeter	in	EtOH.	Melting	






















To	 a	 solution	 of	 N‐acetyl	 aziridine	 1	 (1.0	 mmol)	 in	
dichloromethane	 (5	mL)	 was	 added	 InCl3	 (20	mg,	 0.1	mmol)	
and	 thiols	 (2.0	 mmol).	 The	 reaction	 mixture	 was	 stirred	 at	
room	 temperature	 for	 12	 h.	 The	 solids	 were	 filtered	 off	 and	








eq).	 The	 reaction	mixture	was	heated	 at	 80	 °C	 for	 6	h.	Water	
(20	mL)	was	added	and	the	mixture	was	extracted	with	EtOAc	
(3	 ×	 20	 mL).	 The	 organic	 layers	 were	 combined,	 dried	 over	
sodium	 sulfate	 and	 concentrated	 under	 diminished	 pressure.	






CH3‐4′′),	 1.30	 (t,	 J	=	7.2	Hz,	3H,	CH3‐2′),	 1.38	 (m,	 2H,	CH2‐3′′),	
1.54	(m,	2H,	CH2‐2′′),	2.07	(s,	3H,	CH3‐CO),	2.25	(m,	1H,	Ha‐6),	
2.52	(m,	2H,	CH2‐1′′),	2.90	(dd,	J	=	5.5,	17.5	Hz,	1H,	Hb‐6),	3.58	




(1C,	 CH3),	 23.4,	 29.7,	 29.8,	 31.6,	 45.6,	 55.4,	 58.9,	 61.0,	 127.9,	
139.1,	165.5,	171.1.	
Ethyl	 (3R,4R,5S)‐4‐acetamido‐5‐amino‐3‐(phenylthio)cyclo	


















23.3,	 29.8,	 48.4,	 56.5,	 58.7,	 61.0,	 126.6,	 127.7,	 128.3,	 130.7,	
132.3,	133.6,	137.5,	140.7,	165.5,	171.1.	
Ethyl	 (3R,4R,5S)‐4‐acetamido‐5‐amino‐3‐(ethylthio)cyclo	










hex‐1‐ene‐1‐carboxylate	 (3e):	 Color:	 Yellow,	 amorphous	 solid.	
Yield:	39%.	 1H	NMR	(500	MHz,	CDCl3,	δ,	ppm):	1.29	(t,	 J	=	7.2	
Hz,	3H,	CH3‐2′),	2.00	(s,	3H,	Ac),	2.20	(m,	1H,	Ha‐6),	2.83	(dd,	J	=	




7.31	 (m,	 5H,	 Ar‐H).	 13C	 NMR	 (125	MHz,	 CDCl3,	 δ,	 ppm):	 14.1,	







was	 stirred	 under	 hydrogen	 atmosphere	 for	 5	 h.	 The	 solids	





hex‐1‐enecarboxylate	 (4a):	 Color:	 White,	 amorphous	 solid.	
















13C	NMR	 (125	MHz,	 CDCl3,	 δ,	 ppm):	 13.6,	 14.2,	 21.9,	 23.6,	




hex‐1‐ene‐1‐carboxylate	 (4b):	 Color:	 White,	 amorphous	 solid.	
Yield:	 85%.	 [α]D25:	 ‐9.2	 (c	 0.17,	 CHCl3).	 1H	 NMR	 (500	 MHz,	
CDCl3,	δ,	ppm):	1.26	(t,	J	=	7.0	Hz,	3H,	CH3‐2′),	2.00	(s,	3H,	Ac),	
2.03	 (m,	 1H,	 Ha‐6);	 2.80	 (dd,	 J	=	 4.5,	 17.5	 Hz,	 1H,	 Hb‐6),	 3.17	
(ddd,	J	=	4.5,	10.2,	10.2	Hz,	1H,	H‐5),	3.75	(q,	J	=	10.2	Hz,	1H,	H‐
4),	3.90	(br.	d,	J	=	10.5	Hz,	1H,	H‐3),	4.16	(m,	2H,	CH2‐1′),	6.27	






hex‐1‐ene‐1‐carboxylate	 (4c):	 Color:	 Yellow,	 amorphous	 solid.	
Yield:	 83%.	 [α]D25:	 ‐42.9	 (c	 0.14,	 CHCl3).	 1H	 NMR	 (500	 MHz,	
CDCl3,	δ,	ppm):	1.26	(t,	J	=	7.1	Hz,	3H,	CH3‐2′),	1.96	(s,	3H,	Ac),	







20.9,	 23.5,	 32.5,	 49.6,	 50.9,	 57.4,	 60.9,	 126.6,	 128.0,	 129.0,	
130.7,	 132.7,	133.2,	137.4,	140.6,	166.0,	 171.4.	MS	 (ESI,	m/z):	
349	[M+H]+.	
Ethyl	 (3R,4R,5S)‐4‐acetamido‐5‐amino‐3‐(ethylthio)cyclo	
hex‐1‐ene‐1‐carboxylate	 (4d):	 Color:	 Yellow,	 amorphous	 solid.	










hex‐1‐ene‐1‐carboxylate	 (4e):	 Color:	 White,	 amorphous	 solid.	
Yield:	 83%.	 [α]D25:	 ‐113.1	 (c	 0.53,	 CHCl3).	 1H	 NMR	 (500	MHz,	
CDCl3,	δ,	ppm):	1.27	(t,	J	=	7.0	Hz,	3H,	CH3‐2′),	2.05	(s,	3H,	Ac),	











To	 a	 solution	 of	 compound	1	 (0.6	mmol)	 and	 alcohols	 (4	
eq.)	 in	anhydrous	CH2Cl2	(0.5	mL)	was	added	borontrifluoride	
diethyl	 etherate	 (1.5	 eq)	 in	 CH2Cl2	 (0.5	 mL)	 at	 ‐8	 °C.	 The	



















δ,	 ppm):	 0.86‐0.93	 (m,	 2H,	 cyclohexane),	 1.12‐1.29	 (m,	 3H	
cyclohexane),	1.31	(t,	J	=	7.1	Hz,	3H,	CH3‐2′),	1.36‐1.69	(m,	8H,	
cyclohexane	 and	 CH2‐2′′),	 2.03	 (s,	 3H,	 Ac),	 2.73‐2.84	 (m,	 2H,	
CH2‐6),	3.03	(s,	3H,	mesyl),	3.48	(m,	1H,	Ha‐1′′),	3.66	(m,	1H,	Hb‐




sulfonyl)oxy)cyclohex‐1‐ene‐1‐carboxylate	 (5c):	 	 Color:	 White,	
Amorphous	 solid.	 Yield:	 52%.	 1H	 NMR	 (500	 MHz,	 CDCl3,	 δ,	
ppm):	 1.30	 (t,	 J	 =	 7.1	 Hz,	 3H,	 CH3‐2′),	 1.32‐1.39	 (m,	 2H,	
cycloheptane),	 1.49‐1.56	 (m,	 4H,	 cycloheptane),	 1.58‐1.65	 (m,	






sulfonyl)oxy)cyclohex‐1‐ene‐1‐carboxylate	 (5d):	 Color:	 White,	






































dried	 over	 sodium	 sulphate,	 concentrated	 under	 reduced	




cyclohex‐1‐ene‐1‐carboxylate	 (6a):	 Color:	 White,	 amorphous	
solid.	Yield:	71%.	1H	NMR	(500	MHz,	CDCl3,	δ,	ppm):	0.90‐0.97	
(m,	2H,	cyclohexane),	1.13‐1.25	(m,	3H,	cyclohexane),	1.31	(t,	J	







ethoxy)cyclohex‐1‐ene‐1‐carboxylate	 (6b):	 Color:	 Yellow,	
amorphous	 solid.	 Yield:	 88%.	 1H	 NMR	 (500	 MHz,	 CDCl3,	 δ,	
ppm):	 0.86‐0.93	 (m,	 2H,	 cyclohexane),	 1.12‐1.27	 (m,	 3H,	
cyclohexane),	1.30	(t,	J	=	7.1	Hz,	3H,	CH3‐2′),	1.34‐1.69	(m,	8H,	











3.26	 (m,	1H,	H‐3),	 3.62	 (m,	 1H,	H‐1′′),	 4.21	 (q,	 J	=	7.1	Hz,	2H,	
CH2‐1′),	4.32	(m,	1H,	H‐4),	4.56	(m,	1H,	H‐5),	5.71	(d,	J	=	7.0	Hz,	
1H,	NH),	6.77	(s,	1H,	H‐2).	13C	NMR	(125	MHz,	CDCl3,	δ,	ppm):	






















phenoxy)cyclohex‐1‐ene‐1‐carboxylate	 (6f):	 Color:	 Yellow,	
amorphous	 solid.	 Yield:	 47%.	 1H	 NMR	 (500	 MHz,	 CDCl3,	 δ,	
ppm):	1.31	(t,	J	=	7.0	Hz,	3H,	CH3‐2′),	2.02	(s,	3H,	Ac),	2.30	(m,	
1H,	Ha‐6),	2.90	(dd,	J	=	5.5,	17.5	Hz,	1H,	Hb‐6),	3.62	(m,	1H,	H‐3),	














methoxy)cyclohex‐1‐ene‐1‐carboxylate	 (7a):	 Color:	 Yellow,	










ethoxy)cyclohex‐1‐ene‐1‐carboxylate	 (7b):	 Color:	 Yellow,	








NH),	6.76	 (br.	 s,	1H,	H‐2).	 13C	NMR	(125	MHz,	CDCl3,	 δ,	ppm):	




cyclohex‐1‐ene‐1‐carboxylate	 (7c):	 Color:	 Yellow,	 amorphous	
solid.	 	 Yield:	 93%.	 [α]D25:	 ‐88.8	 (c	 1.25,	 CHCl3).	 1H	 NMR	 (500	
MHz,	CDCl3,	δ,	ppm):	1.26	(t,	J	=	7.0	Hz,	3H,	CH3‐2′),	1.32	(m,	2H,	




1H,	 NH),	 6.72	 (br.	 s,	 1H,	 H‐2).	 13C	 NMR	 (125	 MHz,	 CDCl3,	 δ,	










Compounds	 IC50	(μg/mL)	 	 Compounds	 IC50	(μg/mL)	
KB	 MCF‐7	 LU‐1 KB MCF‐7	 LU‐1
4a	 72.0	 38.2	 40.1	 	 7c	 98.7	 97.6	 99.8	
4b	 9.6	 8.0	 8.8	 	 7d	 >100	 >100	 >100	
4c	 39.7	 42.9	 45.0 7e 84.6 72.7	 74.1
4d	 >100	 >100	 >100 7f 15.7 15.0	 15.3
4e	 79.7	 62.5	 82.9 Ellipticine 1.1 0.9	 0.9
7a	 84.9	 80.0	 79.7 Oseltamivir	phosphate >100 >100	 >100














cyclohex‐1‐ene‐1‐carboxylate	 (7e):	 Color:	 Yellow,	 amorphous	
solid.	 Yield:	 88%.	 [α]D25:	 ‐38.75	 (c	 0.5,	 CHCl3).	 1H	 NMR	 (500	
MHz,	CDCl3,	δ,	ppm):	1.16	(t,	J	=	7.0	Hz,	3H,	CH3‐2′),	1.86	(s,	3H,	
Ac),	2.03	(m,	1H,	Ha‐6),	2.65	(dd,	J	=	5.0,	17.5	Hz,	1H,	Hb‐6),	2.75	









phenoxy)cyclohex‐1‐ene‐1‐carboxylate	 (7f):	 Color:	 White,	
amorphous	 solid.	 Yield:	 68%.	 [α]D25:	 ‐50.8	 (c	 1.0,	 CHCl3).	 1H	






1H,	Ar‐H‐6′′),	 7.45	 (d,	 J	=	1.5	Hz,	 1H,	Ar‐H‐3′′).	 13C	NMR	 (125	
MHz,	CDCl3,	δ,	ppm):	14.1,	23.5,	33.9,	49.7,	56.3,	61.0,	68.5,	76.8,	







serum,	 L‐glutamine	 (2	mM),	 penicillin	 G	 (100	UI/mL),	
streptomycin	 (100	μg/mL)	 and	 gentamicin	 (10	μg/mL).	 Stock	
solutions	 of	 compounds	 were	 prepared	 in	 DMSO/H2O	 (1/9),	
and	cytotoxicity	assays	were	carried	out	 in	96‐well	microtiter	
plates	 against	 KB,	 MCF‐7	 and	 LU‐1	 cancer	 cell	 lines	 (3	 ×	
103	cells/mL)	 using	 a	 modification	 of	 the	 published	 method	
[18].	 After	 72	h	 incubation	 at	 37	 °C	 in	 air/CO2	 (95:5)	with	 or	
without	 test	 compounds,	 cell	 growth	 was	 estimated	 by	
colorimetric	measurement	of	stained	living	cells	by	neutral	red.	
Optical	 density	 was	 determined	 at	 540	nm	 with	 a	 Titertek	
Multiscan	 photometer.	 The	 IC50	 value	 was	 defined	 as	 the	
concentration	of	sample	necessary	to	inhibit	the	cell	growth	to	





The	 synthesis	 of	 oseltamivir	 was	 previously	 described	
starting	from	shikimic	acid,	in	which	the	synthesis	via	aziridine	
intermediate	was	considered	to	be	an	effective	method	[19,20].	
The	 approach	 in	 this	 work	 is	 preparation	 of	 ether	 sulfur	 or	
ether	oxygen	at	C‐3	position	of	oseltamivir	analogues	based	on	
ring	 opening	 of	 aziridine	 compound	 by	 different	 thiols	 or	
alcohols.	 Accordingly,	 aziridine	1	was	 obtained	 from	 shikimic	
acid	 through	 five	 steps	 in	high	yields	using	previous	 reported	
methods	[19,20].		
Aziridines	 are	 highly	 strained,	 three‐membered,	 nitrogen	
containing	 heterocycles	 that	 is	 easily	 opened	 by	 nucleo‐
philes	 in	 order	 to	 relieve	 the	 strain.	Yadav	and	co‐workers	
demonstrated	that	the	InCl3	could	promote	the	ring	opening	of	
aziridines	by	nucleophiles	including	thiols	under	mild	reaction	
conditions	 with	 high	 regioselectivity	 [21].	 Consequently,	
aziridine	 1	 was	 successfully	 reacted	 with	 different	 thiols	
(ethylthiol,	 n‐butylthiol,	 benzylthiol,	 thiophenol	 and	 o‐methyl	
thiophenol)	 in	 the	 presence	 of	 InCl3	 at	 room	 temperature	 to	
afford	 compounds	 2a‐e	 in	 high	 yields	 (63‐91%)	 with	 high	
stereoselectivity	 and	 regioselectivity.	 The	 next	 step	 was	
nucleophilic	 replacement	of	OMs	group	at	 the	C‐5	position	by	
the	 N3	 group.	 Treatment	 of	 compounds	 2a‐e	 with	 NaN3	
afforded	the	intermediates	3a‐e.	The	inversion	of	configuration	





in	 the	 presence	 of	 Lindlar’s	 catalyst	 to	 provide	 4a‐e,	
respectively	(Scheme	1)	[19].	
In	 the	 second	 approach,	 the	 analogues	 containing	 ether	
oxygen	at	C‐3	were	also	prepared	starting	from	1	by	aziridine	
ring	opening	with	alcohols	in	the	presence	of	BF3.Et2O	to	yield	
compounds	 5a‐f	 which	 were	 then	 converted	 into	 the	
corresponding	azide	derivatives	6a‐f.	The	series	of	alkyl	or	aryl	
ethers	 at	 C‐3	 7a‐f	 was	 obtained	 from	 the	 corresponding	
intermediates	6a‐f	by	reduction	with	Ph3P	(Scheme	2)	[22].	
The	 synthetic	 compounds	 were	 evaluated	 for	 their	
cytotoxicity	 against	 three	 human	 cancer	 cell	 lines,	 KB	 (mouth	
epidermal	carcinoma	cells),	LU‐1	(human	lung	cancer	cells)	and	
MCF‐7	 (human	breast	 cancer	 cells).	Except	 for	4d,	7c	 and	7d,	
the	 remaining	 compounds	 were	 found	 to	 be	 active	 against	
three	 tested	 cancer	 cell	 lines	 (Table	 1).	 It	 was	 found	 that	
oseltamivir	has	no	cytotoxicity	against	different	cell	 lines	such	
as	 MDCK,	 MRC‐5,	 VERO,	 MK	 and	 293	 cells	 [23].	 Also,	 when	
tested	 against	 KB,	 LU‐1	 and	 MCF‐7	 cell	 lines,	 oseltamivir	
phosphate	had	no	 inhibition	even	at	 the	 concentration	of	100	
µg/mL.	 Thus,	 the	 modification	 of	 alkyl	 groups	 at	 C‐3	 of	 the	
cyclohexene	ring	significantly	increased	the	cytotoxicity	for	this	
class	 of	 compounds.	 In	 order	 to	 compare	 the	 neuraminidase	
inhibition	 activity	 with	 oseltamivir	 phosphate,	 the	 synthetic	
compounds	4a‐e	and	7a‐f	were	also	 evaluated	 for	 their	 in	
vitro	 influenza	 A	 neuraminidase	 inhibitory	 activity	 by	 an	
enzymatic	 assay.	However,	these	compounds	had	no	inhibition	

















oxygen	 at	 C‐3	 position	 for	 cytotoxic	 activity.	 Many	 of	 the	
synthetic	 derivatives	 exhibited	 cytotoxicity	 against	 the	 three	
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